A detailed history of Geneos Wealth Management Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 133 shares of TXG stock, worth $1,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Previous 150 11.33%
Holding current value
$1,534
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 18, 2025

SELL
$7.14 - $11.73 $121 - $199
-17 Reduced 11.33%
133 $1,000
Q1 2025

May 07, 2025

BUY
$8.73 - $16.31 $881 - $1,647
101 Added 206.12%
150 $1,000
Q4 2024

Jan 21, 2025

BUY
$13.18 - $21.31 $645 - $1,044
49 New
49 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.1B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.